Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection
- PMID: 12115878
- DOI: 10.1002/path.1117
Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection
Retraction in
-
Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection.J Pathol. 2012 Oct;228(2):260. J Pathol. 2012. PMID: 23130366 No abstract available.
Abstract
Inflammatory processes can stimulate renal epithelial cells to release cytokines, chemoattractants and matrix proteins into the interstitium, thus contributing to interstitial injury during acute allograft rejection. To test the role of interleukin 17 (IL-17) in this process, cultured human renal epithelial cells (hRECs) were first established and treated with or without human IL-17 (hIL-17) for 2, 4, 8 and 10 h in vitro. Significant elevations of IL-6 and IL-8 levels were noted in the supernatants in a dose-dependent and time-dependent manner, as also for IL-6 mRNA expression. Secondly, using a rat acute allograft rejection model, the correlation between IL-17 expression and histopathological changes was serially studied. The results demonstrated that increased expression of IL-17 protein on infiltrating mononuclear cells (MNCs) was detectable on day 2. This corresponds to the borderline change of acute rejection according to the Banff classification, and it increased progressively to day 5. Serial study of IL-6, IL-8 and IL-17 mRNA expression of the renal allograft confirmed IL-17 mRNA expression in the allograft early on post-transplant day 2, whereas IL-6 and IL-8 expression started on day 3. Thirdly, IL-17 expression was observed in human renal allograft and urinary sediment. IL-17 protein expression was found in human subclinical (borderline) rejection renal allograft biopsy tissue and none in biopsy tissue not showing any evidence of rejection. There was also a 100% detectable rate of IL-17 mRNA expression in the MNCs of urinary sediment of patients with subclinical borderline rejection. These results demonstrate that hRECs exposed to IL-17 can produce inflammatory mediators with the potential to stimulate early alloimmune responses, which may also serve to give warning of acute renal allograft rejection.
Copyright 2002 John Wiley & Sons, Ltd.
Similar articles
-
[Expressions of interleukin-15 and osteopontin mRNA in early stage of acute rejection of renal allograft in rats].Zhonghua Yi Xue Za Zhi. 2010 Mar 16;90(10):698-702. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20450731 Chinese.
-
IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection.Transpl Int. 2001 Sep;14(5):287-98. doi: 10.1007/s001470100344. Transpl Int. 2001. PMID: 11692212
-
Macrophage-derived interleukin-18 in experimental renal allograft rejection.Nephrol Dial Transplant. 2005 Apr;20(4):699-706. doi: 10.1093/ndt/gfh712. Epub 2005 Feb 16. Nephrol Dial Transplant. 2005. PMID: 15716294
-
Urinary tubular biomarkers as potential early predictors of renal allograft rejection.Nephrology (Carlton). 2012 Jan;17(1):11-6. doi: 10.1111/j.1440-1797.2011.01536.x. Nephrology (Carlton). 2012. PMID: 22050577 Review.
-
Granulomatous Tubulointerstitial Nephritis in a Kidney Allograft: Treatment with Interleukin-6 Receptor Antagonist Stabilises Kidney Function.J Clin Med. 2024 Jun 11;13(12):3427. doi: 10.3390/jcm13123427. J Clin Med. 2024. PMID: 38929956 Free PMC article. Review.
Cited by
-
Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection.Immunology. 2012 Jul;136(3):344-51. doi: 10.1111/j.1365-2567.2012.03588.x. Immunology. 2012. PMID: 22444300 Free PMC article.
-
The immunomodulation role of Th17 and Treg in renal transplantation.Front Immunol. 2023 Feb 1;14:1113560. doi: 10.3389/fimmu.2023.1113560. eCollection 2023. Front Immunol. 2023. PMID: 36817486 Free PMC article. Review.
-
Analysis of Interleukin-17 mRNA Level in the Urinary Cells of Kidney Transplant Recipients with Stable Function.Maedica (Bucur). 2017 Dec;12(4):242-245. Maedica (Bucur). 2017. PMID: 29610586 Free PMC article.
-
Differential effects of activated human renal epithelial cells on T-cell migration.PLoS One. 2013 May 22;8(5):e64916. doi: 10.1371/journal.pone.0064916. Print 2013. PLoS One. 2013. PMID: 23717673 Free PMC article.
-
Current data on IL-17 and Th17 cells and implications for graft versus host disease.Einstein (Sao Paulo). 2013 Apr-Jun;11(2):237-46. doi: 10.1590/s1679-45082013000200019. Einstein (Sao Paulo). 2013. PMID: 23843069 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical